Nanogen Hopes to Raise $20M in Convertible Debt to Fatten Working Capital | GenomeWeb
NEW YORK (GenomeWeb News) — Nanogen today said it hopes to raise $20 million in a registered offering unsecured senior convertible notes and warrants to institutional investors.
 
The transaction, which is expected to fund today, will be overseen by Seven Hills Partners. The investors were not disclosed, though in a statement Nanogen CEO Howard Birndorf called them “solid” and “familiar with both our market place and our long term prospects.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.